Flow of participants through the study. by Sedighe Esmaeilzadeh (21100668)

“…Participants were randomly assigned to receive either 5 mg melatonin or placebo for 2 months. The primary outcome was change in overall sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI). …”

Demographic Characteristics of Participants. by Sedighe Esmaeilzadeh (21100668)

“…Participants were randomly assigned to receive either 5 mg melatonin or placebo for 2 months. The primary outcome was change in overall sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI). …”

Comparison of dose-normalized exposure in four species after oral administration of BPN-14136. by Boglarka Racz (1336803)

Inhibition of mineralization by phosphorylated MEPE-ASARM peptide in a 3D collagen/tooth slice culture model. A: by Benjamin Salmon (381317)

Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

“…The IC₅₀ value of <b>Nano-CC1-Acl</b> further decreases to 0.20 ± 0.16 μM in the presence of cysteine, a biothiol. …”

Transforming Small-Molecule Nanoaggregation into Functional Drug Delivery Platforms by JunHyuk Kim (21235657)

“…The IC₅₀ value of <b>Nano-CC1-Acl</b> further decreases to 0.20 ± 0.16 μM in the presence of cysteine, a biothiol. …”

Effects of antenatal DEX-treatment on occludin expression in total brains and brain endothelial fractions of PN4 and PN10 pups. by Winfried Neuhaus (513628)

An overview of study characteristics. by Akhmedkhan Dubayev (17879559)

“…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). …”

Summary of NOS bias assessments. by Akhmedkhan Dubayev (17879559)

“…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). …”

QST characteristics. by Akhmedkhan Dubayev (17879559)

“…</p><p>Results</p><p>Twenty-five studies were included (5 randomized controlled trials, 20 non-randomized controlled trials). …”

Effects of antenatal DEX-treatment on claudin-3 (black bars) and ZO-1 (white bars) expression in total brains and brain endothelial fractions of PN4 and PN10 pups. by Winfried Neuhaus (513628)

Characteristics of cell line models. by Katarzyna Monika Lamperska (4217602)

“…The let-7d expression levels were similar, but the MEAN of GFP fluorescence marker was nearly half lower in the 7d7d line than in 7d. …”

Effects of Common Polymorphisms rs11614913 in <em>miR-196a2</em> and rs2910164 in <em>miR-146a</em> on Cancer Susceptibility: A Meta-Analysis by Wei Xu (28953)

“…Rs11614913 in <em>miR-196a2</em> and rs2910164 in <em>miR-146a</em> are shown to associate with increased/decreased cancer risk. …”

Effects of GCN2 inhibitor GCN2iB on larval mortality of Cry1Ac-treated <i>H. armigera.</i> by Caihong Zhang (1633294)

MiR-29a targets PTEN. by Guangyao Kong (185282)

“…Empty pcDNA3.0 plasmid (200 ng) was used as a negative control. (C) Luciferase reporter gene assay showed that the decreased luciferase activities of PTEN 3′UTR reporter (PTEN 3′UTR-1 or PTEN 3′UTR-2) in HepG2 cells mediated by miR-29a overexpression (200 ng) was rescued by a miR-29a inhibitor in a dose dependent manner (30, 50, and 100 nM). …”

Modulation of Aβ-induced deleterious signaling. by Tao Yang (184280)

“…<p>For each study, LM11A-24 and -31 were present at 100 nM and NGF at 50 or 100 ng/ml. …”

Effects of sialidase treatment on substantia nigra dopamine neurons. by Jay S. Schneider (671374)

“…<p>Sub-acute MPTP treatment (aCSF-MPTP) resulted in significant decreases in the number of tyrosine hydroxylase immunopositive (A.) and Nissl-stained (B.) cells in the substantia nigra pars compacta. …”

Data selection by changes in the firing rate. by Huu Hoang (9188747)

“…<p>A: the histograms of firing rate change by drug treatments (decreased by CBX and increased by PIX) compared to the CON condition. …”

Evoked firing responses to stimuli in the two-cortical-column model. by Farhad Razi (22076077)

Body weight, body composition and glucose metabolism data. by Ditte Olsen Lützhøft (10837857)